ResearcherLanzhou University Second HospitalActive in the last 2 years
Haofei Chen
Matched on ORCID iD 0000-0002-4134-5326; OpenAlex author ID A5034031769. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- Single-cell and spatial transcriptomics uncover a THBS2⁺ CAF-KRT17⁺ malignant cell axis drives progression and immunotherapy resistance in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2026.102939↗
- SLPI/FBW7/c-Myc Axis Reduces Gemcitabine Sensitivity in PDAC by Enhancing Glycolysis and Impairing NK Cell Immunity. Co-author DOI 10.1111/cas.70369↗
- A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer. Co-author DOI 10.3389/fmolb.2023.1298077↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weixiong Zhu · 3 shared papers, 2023–2026 · strength 0.83
- Paper Single-cell and spatial transcriptomics uncover a THBS2⁺ CAF-KRT17⁺ malignant cell axis drives progression and immunoth… DOI 10.1016/j.tranon.2026.102939↗
- Paper SLPI/FBW7/c-Myc Axis Reduces Gemcitabine Sensitivity in PDAC by Enhancing Glycolysis and Impairing NK Cell Immunity. DOI 10.1111/cas.70369↗
- Paper A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic c… DOI 10.3389/fmolb.2023.1298077↗
- Rui Ma · 1 shared paper, 2026 · strength 0.33
- Junhong Guan · 1 shared paper, 2026 · strength 0.33
- Wence Zhou · 1 shared paper, 2026 · strength 0.32
- Guoqing Zhang · 1 shared paper, 2026 · strength 0.32
- Hao Xu · 1 shared paper, 2023 · strength 0.18
- Daoming Liang · 1 shared paper, 2023 · strength 0.18
- Wence Zhou · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.